Abeona Therapeutics (ABEO) Other Operating Expenses (2011 - 2026)

Abeona Therapeutics' Other Operating Expenses history runs 15 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses changed N/A year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $6.1 million (changed N/A YoY), while the FY2025 annual figure was $3.4 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $2.7 million, down from $2.8 million in the prior quarter.
• The five-year high for Other Operating Expenses was $2.8 million in Q4 2025, with the low at -$1.1 million in Q2 2022.
• The 4-year median for Other Operating Expenses is $277000.0 (2022), against an average of $564181.8.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 733.33% in 2022, then soared 6816.67% in 2023.
• Abeona Therapeutics' Other Operating Expenses stood at $277000.0 in 2022, then plunged by 89.17% to $30000.0 in 2023, then surged by 9356.67% to $2.8 million in 2025, then declined by 4.97% to $2.7 million in 2026.
• Business Quant data shows ABEO's Other Operating Expenses at $2.7 million in Q1 2026, $2.8 million in Q4 2025, and $488000.0 in Q3 2025.